Nature Communications (Jan 2016)

BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis

  • Laia Richart,
  • Enrique Carrillo-de Santa Pau,
  • Ana Río-Machín,
  • Mónica P. de Andrés,
  • Juan C. Cigudosa,
  • Víctor J. Sánchez-Arévalo Lobo,
  • Francisco X. Real

DOI
https://doi.org/10.1038/ncomms10153
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 15

Abstract

Read online

c-MYC genomic distribution is dictated by the epigenetic context but the mechanisms are unknown. Here, the authors show that c-MYC requires the chromatin reader BPTF to activate its transcriptional program and promote tumour development in vivo, suggesting that BPTF is a potential target for cancer therapy.